At AWS Re:Invent in Las Vegas, Amazon (Nasdaq:AMZN) subsidiary AWS launched Amazon Omics to help researchers sift through genomic, transcriptomic and proteomic data.
The volume of such data is exploding. The National Human Genome Research Institute estimates that researchers will need approximately 40 exabytes to store genome-sequence data generated internationally by 2025. One exabyte equates to one billion gigabytes. A single human genome alone has around three billion base pairs of DNA.
The Amazon Omics platform is now available in North Virginia, Oregon, Ireland, London, Frankfurt and Singapore.
Amazon’s rival Microsoft (Nasdaq: MSFT) has similar offerings known as Microsoft Genomics and Microsoft Immunomics on its Azure cloud.
AWS notes that with Amazon Omics, it is possible to import and standardize petabytes of data to facilitate analytics with a few clicks of the Amazon Omics console.
Read more